Clinical outcome of stable outpatients with coronary, cerebrovascular or peripheral artery disease, and atrial fibrillation

被引:30
|
作者
Aguilar, Eduardo [2 ]
Maria Garcia-Diaz, Ana [3 ]
Sanchez Munoz-Torrero, Juan Francisco [4 ]
Ramon Alvarez, Lorenzo [5 ]
Piedecausa, Mar [6 ]
Arnedo, Gemma [7 ]
Monreal, Manuel [1 ]
机构
[1] Hosp Badalona Germans Trias & Pujol, Med Interna Serv, Dept Internal Med, Badalona 08916, Barcelona, Spain
[2] Hosp Alcaniz, Dept Internal Med, Alcaniz, Teruel, Spain
[3] ABS Gaudi, Primary Healthcare, Barcelona, Spain
[4] Hosp San Pedro de Alcantara, Dept Internal Med, Caceres, Spain
[5] Hosp Terrassa, Dept Vasc Surg, Barcelona, Spain
[6] Hosp Gen Univ Elche, Dept Internal Med, Alicante, Spain
[7] Hosp Badalona Germans Trias & Pujol, Dept Vasc Surg, Badalona 08916, Barcelona, Spain
关键词
Atrial fibrillation; Ayocardial infarction; Atroke; Bleeding; Antiplatelets; Anticoagulants; ANTITHROMBOTIC THERAPY; MYOCARDIAL-INFARCTION; EUROPEAN-SOCIETY; PREVENT STROKE; TASK-FORCE; RISK; ASPIRIN; CLOPIDOGREL; MANAGEMENT; WARFARIN;
D O I
10.1016/j.thromres.2012.05.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The influence of atrial fibrillation (AF) on outcome in patients with symptomatic atherosclerotic disease has not been thoroughly studied. Methods: FRENA is an ongoing registry of stable outpatients with coronary (CAD), cerebrovascular (CVD), or peripheral (PAD) artery disease. With the aim to guide therapy, we assessed the incidence of subsequent myocardial infarction (MI), ischemic stroke or major bleeding in patients with AF, according to initial presentation. Results: As of June 2011, 3848 patients were recruited: 1436 had CAD, 1104 CVD, and 1308 had PAD. Of these, 470 (12%) had AF: 151 patients with CAD, 157 with CVD, and 162 with PAD. Over a mean follow-up of 16 +/- 13 months, 19 patients with AF developed acute MI, 22 ischemic stroke and 7 bled. Among AF patients with CAD, the incidence of subsequent MI (5.00 events per 100 patient-years; 95% CI: 2.54-8.91) was non-significantly higher than that of stroke (1.48; 95% CI: 0.38-4.04) or major bleeding (1.47; 95% CI: 0.37-4.01). Among those with CVD, the incidence of stroke (5.61; 95% CI: 2.95-9.75) exceeded that of MI (no events) or major bleeding (0.51; 95% CI: 1.24-6.36). Among those with PAD, the incidence of MI (4.41; 95% CI: 2.15-8.10) and stroke (3.93; 95% CI: 1.82-7.46) were similar. Conclusions: CAD patients with AF are at a higher risk of subsequent MI than of stroke. Among those with CVD, the risk of stroke far exceeds that of MI. Those with PAD have a high and similar risk for both events. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:390 / 395
页数:6
相关论文
共 50 条
  • [41] The safety of flecainide for atrial fibrillation in patients with stable coronary artery disease - Fact or fallacy
    Reiffel, James A.
    AMERICAN HEART JOURNAL, 2022, 248 : 163 - 164
  • [42] Peripheral Artery Disease and Atrial Fibrillation The Dangerous Combination
    Keser, Ahmet
    Ozbek, Kerem
    Katlandur, Huseyin
    Ulucan, Seref
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (02) : 237 - 238
  • [43] Aspirin versus no aspirin on top of vitamin K antagonists in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischaemic and bleeding events
    Lemesle, G.
    Ducrocq, G.
    Elbez, Y.
    Van Belle, E.
    Goto, S.
    Cannon, C. P.
    Bauters, C.
    Bhatt, D. L.
    Steg, P. G.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1193 - 1193
  • [44] Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease
    Gremmel, Thomas
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (25): : 2480 - 2481
  • [45] Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease
    Yasuda, Satoshi
    Kaikita, Koichi
    Akao, Masaharu
    Ako, Junya
    Matoba, Tetsuya
    Nakamura, Masato
    Miyauchi, Katsumi
    Hagiwara, Nobuhisa
    Kimura, Kazuo
    Hirayama, Atsushi
    Matsui, Kunihiko
    Ogawa, Hisao
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (12): : 1103 - 1113
  • [46] Glucose control and outcome in patients with stable diabetes and previous coronary, cerebrovascular or peripheral artery disease. Findings from the FRENA Registry
    Camafort, M.
    Alvarez-Rodriguez, L. R.
    Munoz-Torrero, J. F. S.
    Sahuquillo, J. C.
    Lopez-Jimenez, L.
    Coll, R.
    Monreal, M.
    DIABETIC MEDICINE, 2011, 28 (01) : 73 - 80
  • [47] Raised Fibrinogen Levels and Outcome in Outpatients With Peripheral Artery Disease
    Altes, Pere
    Perez, Paulina
    Esteban, Carlos
    Sanchez Munoz-Torrero, Juan Francisco
    Aguilar, Eduardo
    Maria Garcia-Diaz, Ana
    Ramon Alvarez, Lorenzo
    Enrique Jimenez, Pedro
    Carles Sahuquillo, Joan
    Monreal, Manuel
    ANGIOLOGY, 2018, 69 (06) : 507 - 512
  • [48] Thromboembolic events in atrial fibrillation: Different level of risk and pattern between peripheral artery disease and coronary artery disease
    Lin, Yu-Sheng
    Wu, Victor Chien-Chia
    Chen, Yung-Lung
    Liu, Chi-Hung
    Chen, Huang-Chung
    Lee, Wei-Chieh
    Yang, Teng-Yao
    Aboyans, Victor
    Chen, Mien-Cheg
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2021, 114 (03) : 176 - 186
  • [49] Atrial fibrillation and coronary artery disease: Resembling twins?
    Akao, Masaharu
    JOURNAL OF CARDIOLOGY, 2014, 63 (1-2) : 169 - 170
  • [50] EPIDEMIOLOGY OF STABLE CORONARY ARTERY DISEASE AND OF PERIPHERAL ARTERY DISEASE IN PORTUGAL
    Araujo, C.
    Ferro, A.
    Henriques, A.
    VALUE IN HEALTH, 2019, 22 : S556 - S556